Daryl C Pope
Examiner (ID: 2421, Phone: (571)272-2959 , Office: P/2687 )
Most Active Art Unit | 2687 |
Art Unit(s) | 2735, 2736, 2617, 2612, 2685, 2754, 2687, 2632 |
Total Applications | 2954 |
Issued Applications | 2429 |
Pending Applications | 178 |
Abandoned Applications | 347 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7079011
[patent_doc_number] => 20010041678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Compositions and methods for treating cancer'
[patent_app_type] => new
[patent_app_number] => 09/888299
[patent_app_country] => US
[patent_app_date] => 2001-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3185
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041678.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888299
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888299 | Compositions and methods for treating cancer | Jun 20, 2001 | Abandoned |
Array
(
[id] => 6537473
[patent_doc_number] => 20020193371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Drugs which can be used in the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 09/885031
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 2186
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09885031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/885031 | Drugs which can be used in the treatment of cancer | Jun 19, 2001 | Abandoned |
Array
(
[id] => 1400912
[patent_doc_number] => 06537984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-25
[patent_title] => 'Uses of diterpenoid triepoxides as an anti-proliferative agent'
[patent_app_type] => B2
[patent_app_number] => 09/884898
[patent_app_country] => US
[patent_app_date] => 2001-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11742
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537984.pdf
[firstpage_image] =>[orig_patent_app_number] => 09884898
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/884898 | Uses of diterpenoid triepoxides as an anti-proliferative agent | Jun 18, 2001 | Issued |
Array
(
[id] => 1602792
[patent_doc_number] => 06432971
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Method of prevention of prostatic carcinoma with 17-N-monosubstituted-carbamoyl-4-aza-5-androst-1-en-3-ones'
[patent_app_type] => B1
[patent_app_number] => 09/875381
[patent_app_country] => US
[patent_app_date] => 2001-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5843
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432971.pdf
[firstpage_image] =>[orig_patent_app_number] => 09875381
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/875381 | Method of prevention of prostatic carcinoma with 17-N-monosubstituted-carbamoyl-4-aza-5-androst-1-en-3-ones | Jun 5, 2001 | Issued |
Array
(
[id] => 6598738
[patent_doc_number] => 20020042403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Use of vitamin D analogs to treat conditions related to increased oxidative stress'
[patent_app_type] => new
[patent_app_number] => 09/872638
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8365
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042403.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872638
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872638 | Use of vitamin D analogs to treat conditions related to increased oxidative stress | May 31, 2001 | Abandoned |
Array
(
[id] => 5859961
[patent_doc_number] => 20020123531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Triaryl methane dyes and their use as photochemotherapeutic agents'
[patent_app_type] => new
[patent_app_number] => 09/863149
[patent_app_country] => US
[patent_app_date] => 2001-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6948
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123531.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863149
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863149 | Triaryl methane dyes and their use as photochemotherapeutic agents | May 21, 2001 | Abandoned |
Array
(
[id] => 1325311
[patent_doc_number] => 06602874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-05
[patent_title] => 'Heterocyclic carboxamides'
[patent_app_type] => B2
[patent_app_number] => 09/862932
[patent_app_country] => US
[patent_app_date] => 2001-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12045
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 512
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602874.pdf
[firstpage_image] =>[orig_patent_app_number] => 09862932
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/862932 | Heterocyclic carboxamides | May 21, 2001 | Issued |
Array
(
[id] => 6896402
[patent_doc_number] => 20010027192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Formulation comprising antibacterial substance and antiulcer substance'
[patent_app_type] => new
[patent_app_number] => 09/858655
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11340
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20010027192.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858655
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858655 | Formulation comprising antibacterial substance and antiulcer substance | May 16, 2001 | Abandoned |
Array
(
[id] => 6243118
[patent_doc_number] => 20020045603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Method of inhibiting membrane-type matrix metalloproteinase'
[patent_app_type] => new
[patent_app_number] => 09/855067
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8622
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045603.pdf
[firstpage_image] =>[orig_patent_app_number] => 09855067
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/855067 | Method of inhibiting membrane-type matrix metalloproteinase | May 13, 2001 | Abandoned |
Array
(
[id] => 6885127
[patent_doc_number] => 20010039291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Compositions and methods of treatment for cancer or viral infections'
[patent_app_type] => new
[patent_app_number] => 09/851513
[patent_app_country] => US
[patent_app_date] => 2001-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7458
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039291.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851513
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851513 | Compositions and methods of treatment for cancer or viral infections | May 7, 2001 | Abandoned |
Array
(
[id] => 6477592
[patent_doc_number] => 20020022653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Cannabinoid drugs'
[patent_app_type] => new
[patent_app_number] => 09/851122
[patent_app_country] => US
[patent_app_date] => 2001-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3598
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022653.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851122
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851122 | Cannabinoid drugs | May 7, 2001 | Issued |
Array
(
[id] => 5969028
[patent_doc_number] => 20020091092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Use of propionyl L-carnitine for the preparation of a medicament capable of inducing apoptosis'
[patent_app_type] => new
[patent_app_number] => 09/849369
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5778
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091092.pdf
[firstpage_image] =>[orig_patent_app_number] => 09849369
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/849369 | Use of propionyl L-carnitine for the preparation of a medicament capable of inducing apoptosis | May 6, 2001 | Abandoned |
Array
(
[id] => 6880473
[patent_doc_number] => 20010031760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Method of treating a patient having precancerous lesions with quinazoline derivatives'
[patent_app_type] => new
[patent_app_number] => 09/850685
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27417
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031760.pdf
[firstpage_image] =>[orig_patent_app_number] => 09850685
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/850685 | Method of treating a patient having precancerous lesions with quinazoline derivatives | May 6, 2001 | Abandoned |
Array
(
[id] => 5802328
[patent_doc_number] => 20020010213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Methods for identifying and treating resistant tumors'
[patent_app_type] => new
[patent_app_number] => 09/836429
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19638
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010213.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836429
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836429 | Methods for identifying and treating resistant tumors | Apr 16, 2001 | Issued |
Array
(
[id] => 6509039
[patent_doc_number] => 20020025916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Naphthalimide compositions and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/834177
[patent_app_country] => US
[patent_app_date] => 2001-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3536
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025916.pdf
[firstpage_image] =>[orig_patent_app_number] => 09834177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/834177 | Naphthalimide compositions and uses thereof | Apr 11, 2001 | Issued |
Array
(
[id] => 6894224
[patent_doc_number] => 20010016590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol'
[patent_app_type] => new
[patent_app_number] => 09/829944
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7321
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09829944
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/829944 | Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol | Apr 10, 2001 | Abandoned |
Array
(
[id] => 6745628
[patent_doc_number] => 20030022811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer'
[patent_app_type] => new
[patent_app_number] => 09/832752
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5963
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022811.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832752
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832752 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer | Apr 10, 2001 | Abandoned |
Array
(
[id] => 6882892
[patent_doc_number] => 20010049364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'Prevention of cancer'
[patent_app_type] => new
[patent_app_number] => 09/825891
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17249
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20010049364.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825891
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825891 | Prevention of cancer | Apr 4, 2001 | Issued |
Array
(
[id] => 5950892
[patent_doc_number] => 20020006449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Method of treatment of warts and moles'
[patent_app_type] => new
[patent_app_number] => 09/810273
[patent_app_country] => US
[patent_app_date] => 2001-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1212
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006449.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810273
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810273 | Method of treatment of warts and moles | Mar 18, 2001 | Abandoned |
Array
(
[id] => 1504206
[patent_doc_number] => 06465466
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Uses of indolo-2 2,3b -quinoxalines'
[patent_app_type] => B1
[patent_app_number] => 09/810482
[patent_app_country] => US
[patent_app_date] => 2001-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 5055
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465466.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810482
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810482 | Uses of indolo-2 2,3b -quinoxalines | Mar 18, 2001 | Issued |